Funding
Turn ideas into impact
Show Me
Due: January 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-070
Due: January 7, 2027
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
US $500,000
Type
Grant
Source
Federal
Opp Number
PAR-25-079
Due: January 7, 2027
Cancer Research Education Grants Program – Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
US $150,000
Type
Grant
Source
Federal
Opp Number
PAR-23-278
Due: January 7, 2027
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-159
Due: January 7, 2027
Cancer Research Education Grants Program – Research Experiences (R25 Clinical Trial Not Allowed)
US $300,000
Type
Grant
Source
Federal
Opp Number
PAR-23-277
Due: January 7, 2027
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-032
Due: January 7, 2027
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-310
Due: January 7, 2027
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
US $250,000
Type
Grant
Source
Federal
Opp Number
PAR-25-235
Due: January 7, 2027
Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 – Clinical Trials Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-377
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?